WPI 3635 (Levetiracetam extended release 500 mg)

Pill imprint WPI 3635 has been identified as Levetiracetam extended release 500 mg.

Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; new daily persistent headache; neuralgia (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 3635

Levetiracetam extended release 500 mg WPI 3635
Levetiracetam extended release
Imprint:
WPI 3635
Strength:
500 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Pyrrolidine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)